Mark J Hotchkiss is categorized under Internal Medicine Doctors in Fairfield, CT and active since 2010.
Mark J Hotchkiss was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mark J Hotchkiss at the company’s single location by writing to 500 Kings Highway East Building 2, Fairfield, Connecticut CT 06825 or by phoning (203) 336-1252. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mark J Hotchkiss |
Contact Person: | Mark J Hotchkiss |
Address: | 500 Kings Highway East Building 2, Fairfield, Connecticut 06825 |
Phone Number: | (203) 336-1252 |
Website Address: | ctkidney.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Mark J Hotchkiss was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark J Hotchkiss for inquiries that concern Mark J Hotchkiss by calling the company number (203) 336-1252, as your correspondence is most welcome. Additionally, the physical location of the single location of Mark J Hotchkiss can be found at the coordinates 41.172064,-73.229624 as well as the street address 500 Kings Highway East Building 2 in Fairfield, Connecticut 06825.
For its online presence, you may visit Mark J Hotchkiss’s website at ctkidney.com and engage with its social media outlets through on Twitter and on Facebook.